Similar Articles
411 Pain management in patients with hepatocellular carcinoma after transcatheter arterial chemoembolisation: A retrospective study
412 Main factors influencing long-term outcomes of liver transplantation in 2022
413 Adherence to guideline-directed hepatocellular carcinoma screening: A single-center US experience
414 Patients with hepatocellular carcinoma that die during the first year of liver transplantation have high blood sFasL concentrations
415 Possible mechanisms associated with immune escape and apoptosis on anti-hepatocellular carcinoma effect of Mu Ji Fang granules
416 Systemic treatment for unresectable hepatocellular carcinoma
417 Clinical outcomes of lenvatinib plus transarterial chemoembolization with or without programmed death receptor-1 inhibitors in unresectable hepatocellular carcinoma
418 Predictors of early and late hepatocellular carcinoma recurrence
419 Better performance of PIVKA-II for detecting hepatocellular carcinoma in patients with chronic liver disease with normal total bilirubin
420 Network meta-analysis of the prognosis of curative treatment strategies for recurrent hepatocellular carcinoma after hepatectomy
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA